Mandating Exclusive Review of Individual Treatments (MERIT) Act
Sponsored By: Representative Buchanan, Vern [R-FL-16]
Unknown
Summary
Mandating Exclusive Review of Individual Treatments (MERIT) Act This bill specifies that coverage determinations for drugs and biologics under Medicare must be made with respect to each drug or biologic, rather than with respect to a class of drugs or biologics.
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
No Economic Impacts Identified for this Bill
Sponsors & CoSponsors
Sponsor
Buchanan, Vern [R-FL-16]
FL • R
Cosponsors
Rep. Barragán, Nanette Diaz [D-CA-44]
CA • D
Sponsored 10/4/2022
Rep. Fitzpatrick, Brian K. [R-PA-1]
PA • R
Sponsored 10/14/2022
Rep. Ferguson, A. Drew, IV [R-GA-3]
GA • R
Sponsored 10/14/2022
Rep. Dunn, Neal P. [R-FL-2]
FL • R
Sponsored 10/18/2022
Rep. Salazar, Maria Elvira [R-FL-27]
FL • R
Sponsored 10/21/2022
Rep. Miller-Meeks, Mariannette [R-IA-1]
IA • R
Sponsored 10/25/2022
Rep. Smith, Adrian [R-NE-3]
NE • R
Sponsored 10/25/2022
Rep. Rutherford, John H. [R-FL-5]
FL • R
Sponsored 12/13/2022
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov